Jay Hooper
14Patents
5h-index
7Co-inventors
55Inventor score
Filing activity: Feb 9, 2001 → Aug 28, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6562376B2 | DNA vaccines against poxviruses | Chemistry; Metallurgy | 45 | Expired |
| US6451309B2 | Prophylactic and therapeutic monoclonal antibodies | Human Necessities | 14 | Expired |
| US6620412B2 | Prophylactic and therapeutic monoclonal antibodies | Human Necessities | 12 | Expired |
| US7217812B2 | Extraneous DNA sequence that facilitates hantavirus gene expression | Human Necessities | 9 | Expired |
| US8183358B2 | Puumala virus full-length M segment-based DNA vaccines | Physics | 5 | Active |
| US7790182B2 | Protein vaccines against poxviruses | Chemistry; Metallurgy | 5 | Active |
| US9861681B2 | Therapeutic compositions for neutralizing type I interferons, and methods of use | Human Necessities | 4 | Active |
| US8513005B2 | DNA immunogenic composition comprising a full-length modified poxvirus L1R gene fused to a tPA leader sequence | Chemistry; Metallurgy | 3 | Active |
| US8852598B2 | Puumala virus full-length M segment-based DNA vaccines | Chemistry; Metallurgy | 2 | Active |
| US11072649B2 | Systems and methods for the production of human polyclonal antibodies | Chemistry; Metallurgy | 1 | Active |
| US10443073B2 | Sin Nombre virus full-length M segment-based DNA vaccines | Chemistry; Metallurgy | 0 | Active |
| US9315826B2 | Nucleic acids containing a synthetic codon-optimized Sin Nombre virus full-length M gene | Chemistry; Metallurgy | 0 | Active |
| US11155834B2 | Sin Nombre virus full-length M segment-based DNA vaccines | Chemistry; Metallurgy | 0 | Active |
| US10548946B2 | Therapeutic compositions for neutralizing type I interferons, and methods of use | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.